hopes were not high because the pilot trial was designed to cover a 180-day bridge-to-transplant approach. There were concerns about pump thrombosis; therefore, anticoagulation protocols were maximized at that time.
such devices not only as a bridge but also as a definitive therapy.
The second observation was a new pattern of bleeding events: gingiva bleeds, nose bleeds, and gastrointestinal (GI) bleeding became a problem that The response at the time was skeptical, and our subsequent publication was rejected several times because of 2 questions:
1. Is there any proof that the acvWS is caused by the VAD or is there no causal evidence? 2. If acvWS is present in all HMII patients, why do some bleed and others do not?
We retested our patients when one-half of the initial cohort had received heart transplants. We were able to show that the problem was gone when the pump was removed after transplant. The acvWS remained in the second half of the group that was still on the VAD. The first question was now answered (1).
In the meantime, other groups were working on the subject and coming to similar results. The Columbia group reported on acvWS being present in all of the HMII patients tested at their institution. Importantly, they pointed out that the incidence of GI bleeding was an age-dependent process (2). Other groups, such as the Texas Heart Institute, pointed out that GI bleeding was associated with the formation of arteriovenous malformations (AVMs) in the small bowel (3).
It is a straightforward process to establish the diagnosis of acvWS, but it is much more of a challenge for a laboratory to quantify the loss of large monomers.
Because quantitative analysis is usually completed in batches, we were able to compare HMII and HeartWare HVAD patients in a cross-sectional analysis.
We learned from this analysis that all patients had acvWS, and the median value for both devices was Withholding antithrombotic therapy is a step used in many cases, the addition of antifibrinolytic therapy can be a first-line therapy (7), and the infusion of 
